92
Participants
Start Date
March 31, 2012
Primary Completion Date
January 31, 2014
Study Completion Date
January 31, 2014
Eltrombopag
Thrombopoietin receptor agonist
Placebo
Placebo with no active pharmaceutical ingredient
GSK Investigational Site, Taoyuan District
GSK Investigational Site, Tainan City
GSK Investigational Site, Capital Federal
GSK Investigational Site, Turin
GSK Investigational Site, Bangkok
GSK Investigational Site, Brooklyn
GSK Investigational Site, Berlin
GSK Investigational Site, Monza
GSK Investigational Site, Madrid
GSK Investigational Site, Málaga
GSK Investigational Site, Murcia (El Palmar)
GSK Investigational Site, Pamplona
GSK Investigational Site, Haifa
GSK Investigational Site, St. Petersburg
GSK Investigational Site, Khon Kaen
GSK Investigational Site, Bologna
GSK Investigational Site, Valencia
GSK Investigational Site, Petah Tikva
GSK Investigational Site, Ramat Gan
GSK Investigational Site, Mainz
GSK Investigational Site, Tel Aviv
GSK Investigational Site, Rehovot
GSK Investigational Site, Freiburg im Breisgau
GSK Investigational Site, Beersheba
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Los Angeles
GSK Investigational Site, Songkhla
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Krasnodar
GSK Investigational Site, Brno
GSK Investigational Site, Olomouc
GSK Investigational Site, Ostrava
GSK Investigational Site, Prague
GSK Investigational Site, Pokfulam
GSK Investigational Site, Shatin
GSK Investigational Site, Bydgoszcz
GSK Investigational Site, Madrid
GSK Investigational Site, Bangkok
GSK Investigational Site, Rome
GSK Investigational Site, Gdansk
GSK Investigational Site, Lodz
GSK Investigational Site, Lublin
GSK Investigational Site, Barcelona
GSK Investigational Site, Birmingham
GSK Investigational Site, Cardiff
GSK Investigational Site, London
GSK Investigational Site, Manchester
GSK Investigational Site, Romford
GSK Investigational Site, Sheffield
Lead Sponsor
GlaxoSmithKline
INDUSTRY